Synergistic Angiogenesis Promoting Effects of Extracellular Matrix Scaffolds and Adipose-Derived Stem Cells During Wound Repair
The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.
Abstract
Slow vascularization rate is considered one of the main drawbacks of scaffolds used in wound healing. Several efforts, including cellular and acellular technologies, have been made to induce vascular growth in scaffolds. However, thus far, there is no established technology for inducing vascular growth. The aim of this study was to promote the vascularization capacities of scaffolds by seeding adipose-derived stem cells (ADSCs) on them and to compare the vascularization capacities of different scaffolds seeded with ADSCs. Two kinds of extracellular matrix scaffolds (small intestinal submucosa [SIS] and acellular dermal matrix [ADM]) and a kind of composite scaffold (collagen-chondroitin sulfate-hyaluronic acid [Co-CS-HA]) were selected. Subcutaneous implantation analysis showed that the vascularization capacity of SIS and ADM was greater than that of Co-CS-HA. ADSCs seeded in SIS and ADM secreted greater amounts of vascular endothelial growth factor than those seeded in Co-CS-HA. In a murine skin injury model, ADSC-seeded scaffolds enhanced the angiogenesis and wound healing rate compared with the nonseeded scaffolds. Moreover, ADSC-SIS and ADSC-ADM had greater vascularization capacity than that of ADSC-Co-CS-HA. Taken together, these results suggest that ADSCs could be used as a cell source to promote the vascularization capacities of scaffolds. The vascularization capacities of ADSC-seeded scaffolds were influenced by both the vascularization capacities of the scaffolds themselves and their effects on the angiogenic potential of ADSCs; the combination of extracellular matrix scaffolds and ADSCs exhibited synergistic angiogenesis promoting effects.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The biology of VEGF and its receptors
Ferrara, N., Gerber, H.-P., & LeCouter, J. (2003) · Nature Medicine · doi:10.1038/nm0603-669 · Cited by 9,591 · cited 1×
“VEGF was also shown to enhance cell proliferation and angiogenesis.(37) Moreover, the structurally and functionally different molecules in the ECM scaffolds may support the proliferation and secretion of growth factors by the seeded cells.”
Singer, A. J., & Clark, R. A. F. (1999) · New England Journal of Medicine · doi:10.1056/nejm199909023411006 · Cited by 6,106
Secretion of angiogenic and antiapoptotic factors by human adipose stromal cells
Rehman, J., Traktuev, D., Li, J., Merfeld-Clauss, S., Temm-Grove, C. J., Bovenkerk, J. E., Pell, C. L., Johnstone, B. H., Considine, R. V., & March, K. L. (2004) · Circulation · doi:10.1161/01.cir.0000121425.42966.f1 · Cited by 2,269
Comparison of Multi-Lineage Cells from Human Adipose Tissue and Bone Marrow
De Ugarte, D. A., Morizono, K., Elbarbary, A., Alfonso, Z., Zuk, P. A., Zhu, M., Dragoo, J. L., Ashjian, P., Thomas, B., Benhaim, P., et al. (2003) · Cells Tissues Organs · doi:10.1159/000071150 · Cited by 1,173
The extracellular matrix as a biologic scaffold material
Badylak, S. F. (2007) · Biomaterials · doi:10.1016/j.biomaterials.2007.04.043 · Cited by 1,022 · cited 2×
“In addition, ECM is custom designed and manufactured by the resident cells, which is critical for cellular responses to signals in the cellular microenvironment and provides a supportive medium or conduit for the formation of blood vessels.(22) We also detected the inflammatory cell infiltration within the implanted s…”
Cited by
Hu, L., Wang, J., Zhou, X., Xiong, Z., Zhao, J., Yu, R., Huang, F., Zhang, H., & Chen, L. (2016) · Scientific Reports · doi:10.1038/srep32993 · Cited by 678
Self-citationSkin regeneration scaffolds: a multimodal bottom-up approach
Yildirimer, L., Thanh, N. T. K., & Seifalian, A. M. (2012) · Trends in Biotechnology · doi:10.1016/j.tibtech.2012.08.004 · Cited by 286
Biomaterials / bioinks and extrusion bioprinting
Chen, X. B., Fazel Anvari-Yazdi, A., Duan, X., Zimmerling, A., Gharraei, R., Sharma, N. K., Sweilem, S., & Ning, L. (2023) · Bioactive Materials · doi:10.1016/j.bioactmat.2023.06.006 · Cited by 244
Costa, A., Naranjo, J. D., Londono, R., & Badylak, S. F. (2017) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a025676 · Cited by 135
“SIS and dermal ECM implanted subcutaneously showed greater vascularization during remodeling than a scaffold composed of collagen–chondroitin sulfate–hyaluronic acid (Liu et al. 2011).”
Qiu, X., Liu, S., Zhang, H., Zhu, B., Su, Y., Zheng, C., Tian, R., Wang, M., Kuang, H., Zhao, X., et al. (2018) · Stem Cell Research & Therapy · doi:10.1186/s13287-018-0821-5 · Cited by 111
Self-citationWen, Y., Yang, H., Wu, J., Wang, A., Chen, X., Hu, S., Zhang, Y., Bai, D., & Jin, Z. (2019) · Theranostics · doi:10.7150/thno.35914 · Cited by 92
Self-citationCell-Seeded Biomaterial Scaffolds: The Urgent Need for Unanswered Accelerated Angiogenesis
Shokrani, H., Shokrani, A., Sajadi, S. M., Seidi, F., Mashhadzadeh, A. H., Rabiee, N., Saeb, M. R., Aminabhavi, T., & Webster, T. J. (2022) · International Journal of Nanomedicine · doi:10.2147/ijn.s353062 · Cited by 48
Capella-Monsonís, H., De Pieri, A., Peixoto, R., Korntner, S., & Zeugolis, D. I. (2020) · Stem Cell Research & Therapy · doi:10.1186/s13287-020-02021-x · Cited by 42
Metadata
- Authors
- Liu, S., Zhang, H., Zhang, X., Lu, W., Huang, X., Xie, H., Zhou, J., Wang, W., Zhang, Y., Liu, Y., Deng, Z., & Jin, Y.
- Venue
- Tissue Engineering Part A
- Publisher
- SAGE Publications
- Published
- 2011-03
- Volume
- 17
- Issue
- 5-6
- Pages
- 725-739
- ISSN
- 1937-3341 (ISSN-L)
- 1937-335X
- OpenAlex
- W2082092885
- Cited by
- 138
- References
- 5
- FWCI
- 8.79
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.